New Vitiligo Treatment: FDA Approves Ruxolitinib for the Treatment of Vitiligo
The Food and Drug Administration (FDA) approved ruxolitinib (Opzelura) cream 1.5 percent on July 18, according to a statement from Incyte, the manufacturer of the […]
The Food and Drug Administration (FDA) approved ruxolitinib (Opzelura) cream 1.5 percent on July 18, according to a statement from Incyte, the manufacturer of the […]